Central nervous system effects of prenatal selective serotonin reuptake inhibitors: Sensing the signal through the noise

Psychopharmacology

Volumn 227, Issue 4, 2013, Pages 567-582

  Gur, Tamar L ^a   Kim, Deborah R ^a,b   Epperson, C Neill ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Penn Center for the Study of Sex and Gender in Behavioral Health   (United States)

Author keywords

Anxiety; HPA axis; Pain reactivity; Perinatal depression; Perinatal SSRI; Psychomotor development; S100B; Serotonin; Social behavior

Indexed keywords

BIOLOGICAL MARKER; CITALOPRAM; FLUOXETINE; PROTEIN S100B; SEROTONIN; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR;

ABSENCE OF SIDE EFFECTS; ANIMAL BEHAVIOR; ANXIETY; AUTISM; BEHAVIOR CHANGE; BRAIN DEVELOPMENT; DEPRESSION; DRUG EFFECT; DRUG HALF LIFE; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MENTAL DISEASE; MOOD DISORDER; NONHUMAN; OUTCOME ASSESSMENT; PREGNANCY OUTCOME; PRENATAL DRUG EXPOSURE; PRESCRIPTION; PRIORITY JOURNAL; PROGENY; PSYCHOMOTOR DEVELOPMENT; REVIEW; RISK ASSESSMENT; SOCIAL BEHAVIOR;

ANIMALS; DEPRESSIVE DISORDER, MAJOR; FEMALE; FETAL DEVELOPMENT; HUMANS; MENTAL DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; RODENTIA; SEROTONIN; SEROTONIN UPTAKE INHIBITORS;

EID: 84878725264     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-013-3115-8     Document Type: Review

References (136)

1. Abbott LC, Winzer-Serhan UH (2012) Smoking during pregnancy: lessons learned from epidemiological studies and experimental studies using animal models. Crit Rev Toxicol 42:279-303
2. Akbari HM, Whitaker-Azmitia PM, Azmitia EC (1994) Prenatal cocaine decreases the trophic factor S-100β and induced microcephaly: reversal by postnatal 5-HT1A receptor agonist. Neurosci Lett 170:141-144
3. Allen MC (2008) Neurodevelopmental outcomes of preterm infants. Curr Opin Neurol 21:123-128
4. Alwan S, Reefhuis J, Rasmussen SA, Olney RS, Friedman JM (2007) Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med 356:2684-2692
5. Anderson GM (2004) Peripheral and central neurochemical effects of the selective serotonin reuptake inhibitors (SSRIs) in humans and nonhuman primates: assessing bioeffect and mechanisms of action. Int J Dev Neurosci 22:397-404
6. Andrews MH, Matthews SG (2004) Programming of the hypothalamo-pituitary- adrenal axis: serotonergic involvement. Stress 7:15-27
7. Ansorge MS (2004) Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 306:879-881
8. Ansorge MS, Morelli E, Gingrich JA (2008) Inhibition of serotonin but not norepinephrine transport during development produces delayed, persistent perturbations of emotional behaviors in mice. J Neurosci 28:199-207
9. Avishai-Eliner S, Brunson KL, Sandman CA, Baram TZ (2002) Stressed-out, or in (utero)? Trends Neurosci 25:518-524
10. Bairy KL, Madhyastha S, Ashok KP, Bairy I, Malini S (2007) Developmental and behavioral consequences of prenatal fluoxetine. Pharmacology 79:1-11
11. Bakker MK, Kölling P, van den Berg PB, de Walle HEK, de Jong van den B, Lolkje TW (2008) Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands. Br J Clin Pharmacol 65:600-606
12. Bakker MK, De Walle HEK, Wilffert B, de Jong-Van den Berg LTW (2010) Fluoxetine and infantile hypertrophic pylorus stenosis: a signal from a birth defects-drug exposure surveillance study. Pharmacoepidemiol Drug Saf 19:808-813
13. Bale TL (2011) Sex differences in prenatal epigenetic programming of stress pathways. Stress 14:348-356
14. Bennett HA, Einarson A, Taddio A, Koren G, Einarson TR (2004) Prevalence of depression during pregnancy: systematic review. Obstet Gynecol 103:698-709
15. Berger M, Gray JA, Roth BL (2009) The expanded biology of serotonin. Annu Rev Med 60:355-366
16. Bodner KE, Beversdorf DQ, Saklayen SS, Christ SE (2012) Noradrenergic moderation of working memory impairments in adults with autism spectrum disorder. J Int Neuropsychol Soc 18:556-564
17. Bonari L, Pinto N, Ahn E, Einarson A, Steiner M, Koren G (2004) Perinatal risks of untreated depression during pregnancy. Can J Psychiatry 49:726-735
18. Bonnin A, Levitt P (2011) Fetal, maternal, and placental sources of serotonin and new implications for developmental programming of the brain. Neuroscience 197:1-7
19. Brambilla P, Hardan A, di Nemi SU, Perez J, Soares JC, Barale F (2003) Brain anatomy and development in autism: review of structural MRI studies. Brain Res Bull 61:557-569
20. Brennan PA, Pargas R, Walker EF, Green P, Newport DJ, Stowe Z (2008) Maternal depression and infant cortisol: influences of timing, comorbidity and treatment. J Child Psychol Psychiatry 49:1099-1107
21. Casper RC, Fleisher BE, Lee-Ancajas JC, Gilles A, Gaylor E, DeBattista A, Hoyme HE (2003) Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. J Pediatr 142:402-408
22. Casper RC, Gilles AA, Fleisher BE, Baran J, Enns G, Lazzeroni LC (2011) Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development. Psychopharmacol (Berl) 217:211-219
23. Chen C, Lin H (2011) Prenatal care and adverse pregnancy outcomes among women with depression: a nationwide population-based study. Can J Psychiatry 56:273-280
24. Claes S (2009) Glucocorticoid receptor polymorphisms in major depression. Ann N Y Acad Sci 1179:216-228
25. Clancy B, Darlington RB, Finlay BL (2001) Translating developmental time across mammalian species. Neuroscience 105:7-17
26. Coleman FH, Christensen HD, Gonzalez CL, Rayburn WF (1999) Behavioral changes in developing mice after prenatal exposure to paroxetine (Paxil). Am J Obstet Gynecol 181:1166-1171
27. Colvin L, Slack-Smith L, Stanley FJ, Bower C (2012) Early morbidity and mortality following in utero exposure to selective serotonin reuptake inhibitors: a population-based study in Western Australia. CNS Drugs 26:e1-e14
28. Condie BG, Bain G, Gottlieb DI, Capecchi MR (1997) Cleft palate in mice with a targeted mutation in the gamma-aminobutyric acid-producing enzyme glutamic acid decarboxylase 67. Proc Natl Acad Sci 94:11451-11455
29. Croen LA, Grether JK, Yoshida CK, Odouli R, Hendrick V (2011) Antidepressant use during pregnancy and childhood autism spectrum disorders. Arch Gen Psychiatry 68:1104-1112
30. Culiat CT, Stubbs LJ, Woychik RP, Russell LB, Johnson DK, Rinchik EM (1995) Deficiency of the beta 3 subunit of the type A gamma-aminobutyric acid receptor causes cleft palate in mice. Nat Genet 11:344-346
31. Daniels JL, Forssen U, Hultman CM, Cnattingius S, Savitz DA, Feychting M, Sparen P (2008) Parental psychiatric disorders associated with autism spectrum disorders in the offspring. Pediatrics 121:e1357-e1362, e1357-1362
32. Darling RD, Alzghoul L, Zhang J, Khatri N, Paul IA, Simpson KL, Lin RCS (2011) Perinatal citalopram exposure selectively increases locus ceruleus circuit function in male rats. J Neurosci 31:16709-16715
33. Davidson S, Prokonov D, Taler M, Maayan R, Harell D, Gilad I, Weizman A (2009) Effect of exposure to selective serotonin reuptake inhibitors in utero on fetal growth: potential role for the IGF-I and HPA axes. Pediatr Res 65:236-241
34. Davis EP, Sandman CA (2012) Prenatal psychobiological predictors of anxiety risk in preadolescent children. Psychoneuroendocrinology 37:1224-1233
35. Dolovich LR, Addis A, Vaillancourt JM, Power JD, Koren G, Einarson TR (1998) Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case-control studies. BMJ 317:839-843
36. Egaas B, Courchesne E, Saitoh O (1995) Reduced size of corpus callosum in autism. Arch Neurol 52:794-801
37. El Marroun H, Jaddoe VV, Hudziak JJ et al (2012) Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes. Arch Gen Psych 69:706-714
38. Epperson CN, Bale TL (2012) BDNF Val66Met polymorphism and brain-derived neurotrophic factor levels across the female life span: implications for the sex bias in affective disorders. Biol Psychiatry 72:434-436
39. Evans J, Heron J, Francomb H, Oke S, Golding J (2001) Cohort study of depressed mood during pregnancy and after childbirth. BMJ 323:257-260
40. Fanò G, Mariggiò MA, Angelella P et al (1993) The S-100 protein causes an increase of intracellular calcium and death of PC12 cells. Neuroscience 53:919-925
41. Fava M, Kendler KS (2000) Major depressive disorder. Neuron 28:335-341
42. Gaspar P, Cases O, Maroteaux L (2003) The developmental role of serotonin: news from mouse molecular genetics. Nat Rev Neurosci 4:1002-1012
43. Gavin NI, Gaynes BN, Lohr KN, Meltzer-Brody S, Gartlehner G, Swinson T (2005) Perinatal depression: a systematic review of prevalence and incidence. Obstet Gynecol 106:1071-1083
44. Gentile S (2010a) Neurodevelopmental effects of prenatal exposure to psychotropic medications. Depress Anxiety 27:675-686
45. Gentile S (2010b) On categorizing gestational, birth, and neonatal complications following late pregnancy exposure to antidepressants: the prenatal antidepressant exposure syndrome. CNS Spectr 15:167-185
46. Glover V, O'Connor TG, O'Donnell K (2010) Prenatal stress and the programming of the HPA axis. Neurosci Biobehav Rev 35:17-22
47. Greek R, Shanks N, Marks MJ (2011) The history and implications of testing thalidomide on animals. J Philos Sci Law. Volume 11, October
48. Halene TB, Ehrlichman RS, Liang Y, Christian EP, Jonak GJ, Gur TL, Blendy JA, Dow HC, Brodkin ES, Schneider F, Gur RC, Siegel SJ (2009) Assessment of NMDA receptor NR1 subunit hypofunction in mice as a model for schizophrenia. Genes Brain Behav 8:661-675
49. Hansen HH, Sánchez C, Meier E (1997) Neonatal administration of the selective serotonin reuptake inhibitor Lu 10-134-C increases forced swimming-induced immobility in adult rats: a putative animal model of depression? J Pharmacol Exp Ther 283:1333-1341
50. Harris SS, Maciag D, Simpson KL, Lin RC, Paul IA (2011) Dose-dependent effects of neonatal SSRI exposure on adult behavior in the rat. Brain Res 1429:52-60
51. Hendrick V, Stowe ZN, Altshuler LL, Hwang S, Lee E, Haynes D (2003) Placental passage of antidepressant medications. Am J Psychiatry 160:993-996
52. Homberg JR, Schiepers OJG, Schoffelmeer ANM, Cuppen E, Vanderschuren LJMJ (2007) Acute and constitutive increases in central serotonin levels reduce social play behaviour in peri-adolescent rats. Psychopharmacol (Berl) 195:175-182
53. Ishiwata H, Shiga T, Okado N (2005) Selective serotonin reuptake inhibitor treatment of early postnatal mice reverses their prenatal stress induced brain dysfunction. Neuroscience 133:893-901
54. Jablensky AV, Morgan V, Zubrick SR, Bower C, Yellachich L (2005) Pregnancy, delivery, and neonatal complications in a population cohort of women with schizophrenia and major affective disorders. Am J Psychiatry 162:79-91
55. Kahne D, Tudorica A, Borella A, Shapiro L, Johnstone F, Huang W, Whitaker-Azmitia PM (2002) Behavioral and magnetic resonance spectroscopic studies in the rat hyperserotonemic model of autism. Physiol Behav 75:403-410
56. Kalueff AV, Olivier JD, Nonkes LJ, Homberg JR (2010) Conserved role for the serotonin transporter gene in rat and mouse neurobehavioral endophenotypes. Neurosci Biobehav Rev 34:373-386
57. Kessler R, Berglund P, Demler O, Jin R, Walters E (2005) Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication (NCS-R). Arch Gen Psychiatry 62:593-602
58. Kingston D, Sword W, Krueger P, Hanna S, Markle-Reid M (2012) Life course pathways to prenatal maternal stress. J Obstetric Gynecol Neonatal Nurs 41:609-626
59. Kiser D, Steemers B, Branchi I, Homberg JR (2012) The reciprocal interaction between serotonin and social behaviour. Neurosci Biobehav Rev 36:786-798
60. Kogan MD, Blumberg SJ, Schieve LA, Boyle CA, Perrin JM, Ghandour RM, Singh GK, Strickland BB, Trevathan E, van Dyck PC (2009) Prevalence of parent-reported diagnosis of autism spectrum disorder among children in the US, 2007. Pediatrics 124:1395-1403
61. Kornum JB, Nielsen RB, Pedersen L, Mortensen PB, Nørgaard M (2010) Use of selective serotonin-reuptake inhibitors during early pregnancy and risk of congenital malformations: updated analysis. Clin Epidemiol 2:29-36
62. Kurki T, Hiilesmaa V, Raitasalo R, Mattila H, Ylikorkala O (2000) Depression and anxiety in early pregnancy and risk for preeclampsia. Obstet Gynecol 95:487-490
63. Larsson HJ, Eaton WW, Madsen KM, Vestergaard M, Olesen AV, Agerbo E, Schendel D, Thorsen P, Mortensen PB (2005) Risk factors for autism: perinatal factors, parental psychiatric history, and socioeconomic status. Am J Epidemiol 161:916-925, discussion 926-928; 916-925; discussion 926-928
64. Lillycrop KA, Burdge GC (2011) The effect of nutrition during early life on the epigenetic regulation of transcription and implications for human diseases. J Nutrigenet Nutrigenomics 4:248-260
65. Lira A, Zhou M, Castanon N, Ansorge MS, Gordon JA, Francis JH, Bradley-Moore M, Lira J, Underwood MD, Arango V, Kung HF, Hofer MA, Hen R, Gingrich JA (2003) Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice. Biol Psychiatry 54:960-971
66. Lisboa SFS, Oliveira PE, Costa LC, Venâncio EJ, Moreira EG (2007) Behavioral evaluation of male and female mice pups exposed to fluoxetine during pregnancy and lactation. Pharmacology 80:49-56
67. Louik C, Lin AE, Werler MM, Hernández-Díaz S, Mitchell AA (2007) First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. N Engl J Med 356:2675-2683
68. Lucki I (1997) The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. Behav Pharmacol 8:523-532
69. Malm H, Artama M, Gissler M, Ritvanen (2011) A selective serotonin reuptake inhibitors and risk for major congenital anomalies. Obstet Gynecol 118:111-120
70. Marinoni E, Korebrits C, Di Iorio R, Cosmi EV, Challis JR (1998) Effect of betamethasone in vivo on placental corticotropin-releasing hormone in human pregnancy. Am J Obstet Gynecol 178:770-778
71. McEwen BS (2008) Central effects of stress hormones in health and disease: understanding the protective and damaging effects of stress and stress mediators. Eur J Pharmacol 583:174-185
72. McLean M, Bisits A, Davies J, Woods R, Lowry P, Smith R (1995) A placental clock controlling the length of human pregnancy. Nat Med 1:460-463
73. Merali Z, Levac C, Anisman H (2003) Validation of a simple, ethologically relevant paradigm for assessing anxiety in mice. Biol Psychiatry 54:552-565
74. Miller RP, Becker BA (1975) Teratogenicity of oral diazepam and diphenylhydantoin in mice. Toxicol Appl Pharmacol 32:53-61
75. Misri S, Reebye P, Kendrick K, Carter D, Ryan D, Grunau RE, Oberlander TF (2006) Internalizing behaviors in 4-year-old children exposed in utero to psychotropic medications. Am J Psychiatry 163:1026-1032
76. Morrison JL, Riggs KW, Chien C, Gruber N, McMillen IC, Rurak DW (2004) Chronic maternal fluoxetine infusion in pregnant sheep: effects on the maternal and fetal hypothalamic-pituitary-adrenal axes. Pediatr Res 56:40-46
77. Moses-Kolko EL, Bogen D, Perel J, Bregar A, Uhl K, Levin B, Wisner KL (2005) Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications. JAMA 293:2372-2383
78. Mulder EJH, Ververs FF, de Heus R, Visser GHA (2011) Selective serotonin reuptake inhibitors affect neurobehavioral development in the human fetus. Neuropsychopharmacology 36:1961-1971
79. Nagarajan R, Darlington RB, Finlay BL, Clancy B (2010) ttime: an R package for translating the timing of brain development across mammalian species. Neuroinformatics 8:201-205
80. Nijenhuis CM, ter Horst PGJ, van Rein N, Wilffert B, Jong-van den Berg LTW (2012a) Disturbed development of the enteric nervous system after in utero exposure of selective serotonin re-uptake inhibitors and tricyclic antidepressants. Part 1: literature review. Br J Clin Pharmacol 73:16-26
81. Nijenhuis CM, ter Horst PG, van Rein N, Wilffert B, de Jong-van den Berg LT (2012b) Disturbed development of the enteric nervous system after in utero exposure of selective serotonin re-uptake inhibitors and tricyclic antidepressants. Part 2: testing the hypotheses. Br J Clin Pharmacol 73:126-134
82. Nishiyama H, Takemura M, Takeda T, Itohara S (2002) Normal development of serotonergic neurons in mice lacking S100B. Neurosci Lett 321:49-52
83. Noorlander CW, Ververs FFT, Nikkels PGJ, van Echteld CJA, Visser GHA, Smidt MP (2008) Modulation of serotonin transporter function during fetal development causes dilated heart cardiomyopathy and lifelong behavioral abnormalities. PLoS One 3:e2782-e2782
84. Nulman I, Rovet J, Stewart DE, Wolpin J, Gardner HA, Theis JG, Kulin N, Koren G (1997) Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med 336:258-262
85. Nulman I, Rovet J, Stewart DE, Wolpin J, Pace-Asciak P, Shuhaiber S, Koren G (2002) Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study. Am J Psychiatry 159:1889-1895
86. Nulman I, Koren G, Rovet J, Barrera M, Pulver A, Streiner D, Feldman B (2012) Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression. Am J Psychiatry 169:1165-1174
87. Oberlander TF, Eckstein Grunau R, Fitzgerald C, Ellwood AL, Misri S, Rurak D, Riggs KW (2002) Prolonged prenatal psychotropic medication exposure alters neonatal acute pain response. Pediatr Res 51:443-453
88. Oberlander TF, Grunau RE, Fitzgerald C, Papsdorf M, Rurak D, Riggs W (2005) Pain reactivity in 2-month-old infants after prenatal and postnatal serotonin reuptake inhibitor medication exposure. Pediatrics 115:411-425
89. Oberlander TF, Warburton W, Misri S, Aghajanian J, Hertzman C (2006) Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Arch Gen Psychiatry 63:898-906
90. Oberlander TF, Reebye P, Misri S, Papsdorf M, Kim J, Grunau RE (2007) Externalizing and attentional behaviors in children of depressed mothers treated with a selective serotonin reuptake inhibitor antidepressant during pregnancy. Arch Pediatr Adolesc Med 161:22-29
91. Oberlander TF, Grunau R, Mayes L, Riggs W, Rurak D, Papsdorf M, Misri S, Weinberg J (2008a) Hypothalamic-pituitary-adrenal (HPA) axis function in 3-month old infants with prenatal selective serotonin reuptake inhibitor (SSRI) antidepressant exposure. Early Hum Dev 84:689-697
92. Oberlander TF, Weinberg J, Papsdorf M, Grunau R, Misri S, Devlin AM (2008b) Prenatal exposure to maternal depression, neonatal methylation of human glucocorticoid receptor gene (NR3C1) and infant cortisol stress responses. Epigenetics 3:97-106
93. Oberlander TF, Gingrich JA, Ansorge MS (2009) Sustained neurobehavioral effects of exposure to SSRI antidepressants during development: molecular to clinical evidence. Clin Pharmacol Ther 86:672-677
94. Oberlander TF, Papsdorf M, Brain UM, Misri S, Ross C, Grunau RE (2010) Prenatal effects of selective serotonin reuptake inhibitor antidepressants, serotonin transporter promoter genotype (SLC6A4), and maternal mood on child behavior at 3 years of age. Arch Pediatr Adolesc Med 164:444-451
95. O'Connor TG, Bergman K, Sarkar P, Glover V (2012) Prenatal cortisol exposure predicts infant cortisol response to acute stress. Dev Psychobiol. doi: 10.1002/dev.21007
96. O'Connor TG, Ben-Shlomo Y, Heron J, Golding J, Adams D, Glover V (2005) Prenatal anxiety predicts individual differences in cortisol in pre-adolescent children. Biol Psychiatry 58:211-217
97. Ogawa T, Mikuni M, Kuroda Y, Muneoka K, Mori KJ, Takahashi K (1994) Effects of the altered serotonergic signalling by neonatal treatment with 5,7-dihydroxytryptamine, ritanserin or clomipramine on the adrenocortical stress response and the glucocorticoid receptor binding in the hippocampus in adult rats. J Neural Transm Gen Sect 96:113-123
98. Olivier JDA, Vallès A, van Heesch F, Afrasiab-Middelman A, Roelofs JJPM, Jonkers M, Peeters EJ, Korte-Bouws GAH, Dederen JP, Kiliaan AJ, Martens GJ, Schubert D, Homberg JR (2011) Fluoxetine administration to pregnant rats increases anxiety-related behavior in the offspring. Psychopharmacol (Berl) 217:419-432
99. Olsson A, Phelps EA (2007) Social learning of fear. Nat Neurosci 10:1095-1102
100. Pawluski JL, Galea LA, Brain U, Papsdorf M, Oberlander TF (2009) Neonatal S100B protein levels after prenatal exposure to selective serotonin reuptake inhibitors. Pediatrics 124:662-670
101. Pawluski JL, Rayen I, Niessen NA, Kristensen S, van Donkelaar EL, Balthazart J, Steinbusch HW, Charlier TD (2012a) Developmental fluoxetine exposure differentially alters central and peripheral measures of the HPA system in adolescent male and female offspring. Neuroscience 220:131-141
102. Pawluski JL, Brain UM, Underhill CM, Hammond GL, Oberlander TF (2012b) Prenatal SSRI exposure alters neonatal corticosteroid binding globulin, infant cortisol levels, and emerging HPA function. Psychoneuroendocrinology 37:1019-1028
103. Pedersen LH, Henriksen TB, Olsen J (2010) Fetal exposure to antidepressants and normal milestone development at 6 and 19 months of age. Pediatrics 125:600-608
104. Pedersen LH, Henriksen TB, Bech BH, Licht RW, Kjaer D, Olsen J (2013) Prenatal antidepressant exposure and behavioral problems in early childhood - a cohort study. Acta Psychiatr Scand 127:126-135
105. Petersen I, Gilbert RE, Evans SJW, Man S, Nazareth I (2011) Pregnancy as a major determinant for discontinuation of antidepressants: an analysis of data from The Health Improvement Network. J Clin Psychiatry 72:979-985
106. Piven J, Bailey J, Ranson BJ, Arndt S (1998) No difference in hippocampus volume detected on magnetic resonance imaging in autistic individuals. J Autism Dev Disord 28:105-110
107. Popa D, Léna C, Alexandre C, Adrien J (2008) Lasting syndrome of depression produced by reduction in serotonin uptake during postnatal development: evidence from sleep, stress, and behavior. J Neurosci 28:3546-3554
108. Prathiba J, Kumar KB, Karanth KS (1998) Hyperactivity of hypothalamic pituitary axis in neonatal clomipramine model of depression. J Neural Transm 105:1335-1339
109. Rampono J, Simmer K, Ilett KF, Hackett LP, Doherty DA, Elliot R, Kok CH, Coenen A, Forman T (2009) Placental transfer of SSRI and SNRI antidepressants and effects on the neonate. Pharmacopsychiatry 42:95-100
110. Rayen I, van den Hove DL, Prickaerts J, Steinbusch HW, Pawluski JL (2011) Fluoxetine during development reverses the effects of prenatal stress on depressive-like behavior and hippocampal neurogenesis in adolescence. PLoS One 6:e24003-e24003
111. Ribas et al (2008) Neonatal administration of fluoxetine did not alter the anxiety indicators, but decreased the locomotor activity in adult rats in the elevated plus-maze. Arq Neuropsiquiatr 66:844-847
112. Rodriguez-Porcel F, Green D, Khatri N, Harris SS, May WL, Lin RC, Paul IA (2011) Neonatal exposure of rats to antidepressants affects behavioral reactions to novelty and social interactions in a manner analogous to autistic spectrum disorders. Anat Rec (Hoboken) 294:1726-1735
113. Rosenberg L, Mitchell AA, Parsells JL, Pashayan H, Louik C, Shapiro S (1983) Lack of relation of oral clefts to diazepam use during pregnancy. N Engl J Med 3091282-5
114. Salisbury AL, Wisner KL, Pearlstein T, Battle CL, Stroud L, Lester BM (2011) Newborn neurobehavioral patterns are differentially related to prenatal maternal major depressive disorder and serotonin reuptake inhibitor treatment. Depress Anxiety 28:1008-1019
115. Sankoorikal GMV, Kaercher KA, Boon CJ, Lee JK, Brodkin ES (2006) A mouse model system for genetic analysis of sociability: C57BL/6J versus BALB/cJ inbred mouse strains. Biol Psychiatry 59:415-423
116. Schack-Nielsen L, Michaelsen KF, Gamborg M, Mortensen EL, Sørensen TIA (2010) Gestational weight gain in relation to offspring body mass index and obesity from infancy through adulthood. Int J Obes (Lond) 34:67-74
117. Schroeder JW, Smith AK, Brennan PA, Conneely KN, Kilaru V, Knight BT, Newport DJ, Cubells JF, Stowe ZN (2012) DNA methylation in neonates born to women receiving psychiatric care. Epigenetics 7:409-414
118. Selinfreund RH, Barger SW, Pledger WJ, Van Eldik LJ (1991) Neurotrophic protein S100β stimulates glial cell proliferation. Proc Natl Acad Sci 88:3554-3558
119. Simpson KL, Weaver KJ, de Villers-Sidani E, Lu JY, Cai Z, Pang Y, Rodriguez-Porcel F, Paul IA, Merzenich M, Lin RCS (2011) Perinatal antidepressant exposure alters cortical network function in rodents. Proc Natl Acad Sci U S A 108:18465-18470
120. Smit-Rigter LA, Noorlander CW, von Oerthel L, Chameau P, Smidt MP, van Hooft JA (2012) Prenatal fluoxetine exposure induces life-long serotonin 5-HT receptor-dependent cortical abnormalities and anxiety-like behaviour. Neuropharmacology 62:865-870
121. Suri R, Hellemann G, Stowe ZN, Cohen LS, Aquino A, Altshuler LL (2011) A prospective, naturalistic, blinded study of early neurobehavioral outcomes for infants following prenatal antidepressant exposure. J Clin Psychiatry 72:1002-1007
122. Talge NM, Neal C, Glover V (2007) Antenatal maternal stress and long-term effects on child neurodevelopment: how and why? J Child Psychol Psychiatry 48:245-261
123. Van den Hove DL, Steinbusch HW, Bruschettini M et al (2006) Prenatal stress reduces S100B in the neonatal rat hippocampus. Neuroreport 17:1077-1080
124. Ververs T, Kaasenbrood H, Visser G, Schobben F, Jong-van dB, Egberts T (2006) Prevalence and patterns of antidepressant drug use during pregnancy. Eur J Clin Pharmacol 62:863-870
125. Vorhees CV, Weisenburger WP, Minck DR (2001) Neurobehavioral teratogenic effects of thalidomide in rats. Neurotoxicol Teratol 23:255-264
126. Vucetic Z, Kimmel J, Totoki K, Hollenbeck E, Reyes TM (2010) Maternal high-fat diet alters methylation and gene expression of dopamine and opioid-related genes. Endocrinology 151:4756-4764
127. Wee EL, Zimmerman EF (1983) Involvement of GABA in palate morphogenesis and its relation to diazepam teratogenesis in two mouse strains. Teratology 28:15-22
128. West CHK, Ritchie JC, Weiss JM (2010) Paroxetine-induced increase in activity of locus coeruleus neurons in adolescent rats: implication of a countertherapeutic effect of an antidepressant. Neuropsychopharmacology 35:1653-1663
129. Weikum WM, Oberlander TF, Hensch TK, Werker JF (2012) Prenatal exposure to antidepressants and depressed maternal mood alter trajectory of infant speech perception. Proc Natl Acad Sci 109:17221-17227
130. Whitaker-Azmitia PM, Azmitia EC (1994) Astroglial 5-HT1a receptors and S-100 beta in development and plasticity. Perspect Dev Neurobiol 2:233-238
131. Whitaker-Azmitia PM (2001) Serotonin and brain development: role in human developmental diseases. Brain Res Bull 56:479-485
132. Williams SK, Lauder JM, Johns JM (2011) Prenatal cocaine disrupts serotonin signaling-dependent behaviors: implications for sex differences, early stress and prenatal SSRI exposure. Curr Neuropharmacol 9:478-511
133. Winningham-Major F, Staecker JL, Barger SW, Coats S, Vaneldik LJ (1989) Neurite extension and neuronal survival activities of recombinant S100β proteins that differ in the content and position of cysteine residues. J Cell Biol 109:3063-3071
134. Yonkers KA, Wisner KL, Stewart DE, Oberlander TF, Dell DL, Stotland N, Ramin S, Chaudron L, Lockwood C (2009) The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Obstet Gynecol 114:703-713
135. Yonkers KA, Norwitz ER, Smith MV, Lockwood CJ, Gotman N, Luchansky E, Lin H, Belanger K (2012) Depression and serotonin reuptake inhibitor treatment as risk factors for preterm birth. Epidemiology 23:677-685
136. Zeskind PS, Stephens LE (2004) Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior. Pediatrics 113:368-375